PharmaResearch's 5th Global Symposium Unveils New Developments
PharmaResearch Successfully Holds Its 5th Global Symposium
PharmaResearch, under the leadership of CEO Ki Seock Kang and Thinkyou Kim, recently hosted its fifth Global Symposium (PGS), a significant event showcasing advances in the field of regenerative medicine. The symposium took place at the beautiful Lakai Sandpine Resort, attracting a diverse group of around 600 aesthetic and medical professionals from 25 different countries worldwide. This year's participation highlighted the international interest and the growing significance of the innovative product, Rejuran.
Significance of Rejuran in Aesthetic Medicine
At the centerpiece of the symposium was Rejuran, an advanced skin treatment utilizing PharmaResearch's proprietary DOT™ (DNA Optimizing Technology). This technology has been crucial in improving the effectiveness of aesthetic products, capturing the attention of attendees eager to learn more about cutting-edge techniques and applications.
Engaging Activities and Expert Panels
The first day of the symposium included an enlightening visit to the Inland Water Life Resources Center. Attendees were given an in-depth look at how domestic salmon, a primary resource for PDRN and PN, plays an essential role in the development of Rejuran. Participants also toured PharmaResearch's manufacturing facilities, gaining valuable insights into the meticulous processes that ensure the highest quality of their products from raw material to packaging.
Key Discussions and Launch of the IRC
Day two featured renowned experts such as Dr. Michael J. Kim, Dr. Nark Kyoung Rho, and Dr. Steven Liew. These medical professionals shared the latest findings and insights about DOT™PN and the efficacy of Rejuran through a series of inspiring lectures. The creation of the International Research Committee (IRC) was announced, which aims to facilitate global research focused on Rejuran and its applications in various skin types.
Global Collaboration for Enhanced Research
Dr. Atchima Suwanchinda, a key member of the newly formed IRC, stated, "Rejuran has demonstrated consistent efficacy and safety across different skin types." This commitment to research indicates an ongoing endeavor to establish Rejuran as a trusted medical device, ensuring that healthcare professionals around the globe can safely utilize its benefits for their patients.
An official from PharmaResearch pointed out the significance of bringing together medical professionals from around the world. This collaboration is essential to enhance the understanding and clinical applications of Rejuran, making it a trusted name in the medical field. The IRC's formation reflects a strong commitment to activating global research and achieving effective solutions tailored to various needs.
About PharmaResearch
PharmaResearch is a pioneering biopharmaceutical company committed to improving quality of life through regenerative medicine. With a diverse portfolio that encompasses medicines, medical devices, cosmetics, and supplements, PharmaResearch utilizes its core ingredients, DOT™ PDRN and DOT™ PN, protected by an extensive suite of patents. The company, headquartered in Seongnam, also operates a subsidiary in Costa Mesa, California.
For more information about PharmaResearch, visit http://pharmaresearch.co.kr/en/ and connect with them on LinkedIn.
Frequently Asked Questions
What is the significance of the Global Symposium held by PharmaResearch?
The Global Symposium allows medical professionals worldwide to share insights on Rejuran and related innovations in aesthetic medicine, promoting collaboration and research.
Who are the key speakers at the symposium?
Prominent speakers included Dr. Michael J. Kim, Dr. Nark Kyoung Rho, and Dr. Steven Liew, who provided valuable insights into recent advancements in the field.
What is Rejuran and its application?
Rejuran is an innovative skin treatment derived from a proprietary technology that aims to improve skin quality and rejuvenation for various skin types.
What role does the International Research Committee (IRC) play?
The IRC aims to conduct global research on Rejuran, enhancing the understanding of its clinical efficacy and making it a trusted medical solution.
How can I learn more about PharmaResearch?
For more information, visit their official website or their LinkedIn page to stay updated on their latest research and product developments.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
